The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 125.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.00%)
Open: 127.50
High: 127.50
Low: 127.50
Prev. Close: 127.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Fundraising

21 Dec 2011 14:00

RNS Number : 4326U
Transense Technologies PLC
21 December 2011
 



Transense Technologies plc (the "Company")

 

21 December 2011

 

Result of Fundraising - £1,332,696 raised

 

The Company is pleased to report that it has received subscriptions under the Offer to Warrant holders for 22,243,240 Subscription Shares and accordingly will issue 11,121,606 Bonus Shares. The Company has also taken the opportunity, in response to investor demand, to issue a further 11,058,333 new ordinary shares of 1p each ("Ordinary Shares") at 3 pence per share to new and existing investors to raise, in aggregate, £1,332,696 (before expenses).

 

As previously announced, the proceeds of the Fundraising will be used to further develop the Company's strategy, and in particular to accelerate the pace at which it addresses the opportunities arising within the IntelliSAW division, and for general working capital purposes.

 

The new Ordinary Shares (including the Bonus Shares) to be issued pursuant to the Fundraising will be credited as fully paid and will rank pari passu with the existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

 

The Company will apply for admission of the new Ordinary Shares to be traded on the AIM market of the London Stock Exchange. It is expected that Admission will take place and that trading will commence on 29 December 2011.

 

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following completion of the Fundraising will consist of 176,665,346 Ordinary Shares with one voting right per share. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

Capitalised terms used, but not defined in this announcement, have the same meanings as set out in the announcement released by the Company on 21 November 2011.

The Chairman, David Kleeman, said:

"We are very pleased by the level of support shown by shareholders in these challenging economic and market conditions. The Board believes that supported by the proceeds from the Fundraising, the Company is well on its way to generating significant income from its new revenue channels."

 

Contacts:

 

Transense Technologies PLC

Graham Storey 01869 238380

David Kleeman 020 7430 9329

 

Hybridan LLP - Financial adviser and Broker

Claire Noyce/Tim Goodman /Deepak Reddy- 020 7947 4350

 

Brewin Dolphin - Nominated Adviser

Neil Baldwin 0845 213 4730

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAAFASXFFFF
Date   Source Headline
2nd Nov 200712:53 pmRNSConference Call
26th Oct 20077:30 amRNSConference call
24th Oct 200711:02 amRNSHolding(s) in Company
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company
11th Oct 200710:34 amRNSStatement re. Suspension
11th Oct 200710:30 amRNSSuspension - Transense Tech.
28th Sep 20077:03 amRNSInterim Results
25th Sep 20074:25 pmRNSHolding(s) in Company
9th Aug 200711:44 amRNSAIM Rule 26 Compliance
8th Aug 200712:11 pmRNSPatent Agreement
20th Jun 20073:45 pmRNSDirector/PDMR Shareholding
12th Jun 20073:39 pmRNSTotal Voting Rights
25th May 20073:10 pmRNSAGM Statement
24th May 200711:30 amRNSAGM Statement
10th May 20076:04 pmRNSDirector/PDMR Shareholding
19th Apr 20078:00 amRNSDirector/PDMR Shareholding
17th Apr 200710:29 amRNSDirector Resignation
11th Apr 200712:17 pmRNSDirector/PDMR Shareholding
10th Apr 20074:16 pmRNSHolding(s) in Company
30th Mar 20077:03 amRNSFinal Results
14th Mar 20073:49 pmRNSHolding(s) in Company
8th Mar 20072:59 pmRNSHolding(s) in Company
1st Mar 20075:32 pmRNSHolding(s) in Company
26th Feb 20074:14 pmRNSHolding(s) in Company
22nd Feb 20072:20 pmRNSHolding(s) in Company
22nd Feb 20072:15 pmRNSHolding(s) in Company
14th Feb 20074:05 pmRNSHolding(s) in Company
15th Jan 20075:51 pmRNSHolding(s) in Company
10th Jan 20071:45 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSRe Agreement
27th Nov 20067:01 amRNSRe Agreement
13th Nov 200612:18 pmRNSHolding(s) in Company
8th Nov 20063:35 pmRNSHolding(s) in Company
3rd Nov 20067:00 amRNSMichelin launches TPMS
1st Nov 20065:31 pmRNSHolding(s) in Company
31st Oct 20064:23 pmRNSHolding(s) in Company
30th Oct 20069:40 amRNSStatement re Press Comment
19th Oct 20064:19 pmRNSHolding(s) in Company
22nd Sep 20067:01 amRNSInterim Results
22nd Sep 20067:01 amRNSAgreement with Lear Corp.
22nd Sep 20067:01 amRNSHolding(s) in Company
18th Sep 200612:02 pmRNSHolding(s) in Company
15th Sep 20062:23 pmRNSHolding(s) in Company
7th Jul 20064:44 pmRNSHolding(s) in Company
6th Jul 20067:01 amRNSRe Agreement
13th Jun 200612:24 pmRNSHolding(s) in Company
13th Jun 200612:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.